GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.

The Philadelphia Department of Public Health has released its 2023 Annual Report on Hepatitis B, C, and D in the city. The ...

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...

Two sexually transmitted infections are spreading faster than ever. Our expert guide tells you everything you need to know, ...

An antisense drug in development at GSK has shown further activity against hepatitis B virus (HBV) in a mid-stage trial, setting up a phase 3 assessment next year to see if it could offer a ...

Hepatitis B affects almost 300 million people worldwide, according to GSK, and while nucleoside/nucleotide analogue (NA) drugs to treat it are available – such as Gilead’s polymerase inhibitor ...

Many readers wrote to express their strong opposition to Robert F. Kennedy Jr.’s nomination to head the Department of Health and Human Services, which this week cleared a Senate committee vote and ...

The Louisiana Republican, who led a hepatitis B vaccination campaign before entering politics, has expressed concerns about ...

Event of the Heart, which is the primary fundraiser for MCAVHN Care and Prevention Network takes place on Feb. 15 at the ...

That is about to change, with $6 million awarded to National Cancer Centre Singapore (NCCS) senior consultant surgeon Pierce ...

We are facing a new threat to global health. The COVID-19 pandemic made it clear to health-care providers, public health practitioners, policy makers, and communities that pathogens do not respect ...